Berberine exerts anti-inflammatory effects by inhibiting the TLR4/NF-κB pathway, in addition to its anti-platelet aggregation and anti-atherosclerosis properties, making it a promising drug for the treatment of stroke [78]. Here, NFKB1 is linked to stroke disorder.